FDA NDC Directory · JSON-LD · Markdown

YARTEMLEA

NDC 62225-300 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic namenarsoplimab
Labeler / ManufacturerOmeros Corporation
Marketing categoryBiologic License Application · App BLA761152
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsNARSOPLIMAB (370 mg/2mL)
Marketing started20260120
Package count1

External sources

Source: openFDA. Public-domain (CC0).